Development of iron-chelating agents for clinical use [editorial; comment]
作者： GM Brittenham
DOI: 10.1182/BLOOD.V80.3.569.BLOODJOURNAL803569
关键词: Pharmacology 、 Surgery 、 Chelation 、 Iron Chelating Agents 、 Medicine
摘要:
ashpublications.org
sci-hub.st 参考文章(26)
JB Porter, J Morgan, KP Hoyes, LC Burke, ER Huehns, RC Hider, Relative oral efficacy and acute toxicity of hydroxypyridin-4-one iron chelators in mice. Blood. ,vol. 76, pp. 2389- 2396 ,(1990) , 10.1182/BLOOD.V76.11.2389.2389
FN al-Refaie, B Wonke, AV Hoffbrand, DG Wickens, P Nortey, GJ Kontoghiorghes, Efficacy and possible adverse effects of the oral iron chelator 1,2-dimethyl-3-hydroxypyrid-4-one (L1) in thalassemia major. Blood. ,vol. 80, pp. 593- 599 ,(1992) , 10.1182/BLOOD.V80.3.593.593
S Zevin, G Link, RW Grady, RC Hider, HH Peter, C Hershko, Origin and fate of iron mobilized by the 3-hydroxypyridin-4-one oral chelators: studies in hypertransfused rats by selective radioiron probes of reticuloendothelial and hepatocellular iron stores. Blood. ,vol. 79, pp. 248- 253 ,(1992) , 10.1182/BLOOD.V79.1.248.248
GEORGE J. KONTOGHIORGHES, Design, Properties, and Effective Use of the Oral Chelator L1 and Other Annals of the New York Academy of Sciences. ,vol. 612, pp. 339- 350 ,(1990) , 10.1111/J.1749-6632.1990.TB24321.X
C. HERSHKO, G. LINK, A. PINSON, S. AVRAMOVICI-GRISARU, S. SAREL, H. H. PETER, R. C. HIDER, R. W. GRADY, New Orally Effective Iron Chelators Annals of the New York Academy of Sciences. ,vol. 612, pp. 351- 360 ,(1990) , 10.1111/J.1749-6632.1990.TB24322.X
ANTHONY P. FREEMAN, ROBERT W. GILES, VASILI A. BERDOUKAS, PENELOPE A. TALLEY, I. PROVAN C. MURRAY, Sustained normalization of cardiac function by chelation therapy in thalassaemia major. Clinical and Laboratory Haematology. ,vol. 11, pp. 299- 307 ,(1989) , 10.1111/J.1365-2257.1989.TB00227.X
George J Kontoghiorghes, J Graham Goddard, Arudanthy N Bartlett, Lyndon Sheppard, Pharmacokinetic studies in humans with the oral iron chelator 1,2-dimethyl-3-hydroxypyrid-4-one. Clinical Pharmacology & Therapeutics. ,vol. 48, pp. 255- 261 ,(1990) , 10.1038/CLPT.1990.147
Nancy F. Olivieri, Gideon Koren, Jonathan Harris, Sohail Khattak, Melvin H. Freedman, Douglas M. Templeton, John D. Bailey, B. J. Reilly, Growth failure and bony changes induced by deferoxamine. Journal of Pediatric Hematology Oncology. ,vol. 14, pp. 48- 56 ,(1992) , 10.1097/00043426-199221000-00007
J.B. Porter, E.R. Huehns, 11 The toxic effects of desferrioxamine Baillière's clinical haematology. ,vol. 2, pp. 459- 474 ,(1989) , 10.1016/S0950-3536(89)80027-7
G. J. Kontoghiorghes, A. N. Bartlett, A. V. Hoffbrand, J. G. Goddard, L. Sheppard, J. Barr and, P. Nortey, Long-term trial with the oral iron chelator 1,2-dimethyl-3-hydroxypyrid-4-one (L1). I. Iron chelation and metabolic studies. British Journal of Haematology. ,vol. 76, pp. 295- 300 ,(1990) , 10.1111/J.1365-2141.1990.TB07887.X